Search NLS News

Alexion, AstraZeneca Rare Disease, has entered a definitive purchase and licence agreement for a portfolio of preclinical gene therapy programmes and enabling technologies from Pfizer. The agreement furthers Alexion and AstraZeneca’s commitment to advancing next-generation genomic medicines with the addition of complementary pipeline assets and innovative technologies, it states. Alexion will purchase and licence the […]

AstraZeneca has announced the appointment of Sharon Barr as Executive Vice President, BioPharmaceuticals R&D. Sharon Barr will be responsible for discovery through to late-stage development across Cardiovascular, Renal & Metabolism and Respiratory & Immunology. She will report to Chief Executive Officer, Pascal Soriot and become a member of AstraZeneca’s Senior Executive Team (SET) as of […]

The COVID-19 pandemic certainly cast the spotlight on the possibilities of digital health and Iceland possesses both unique health data for research studies and also a few very interesting companies taking the lead in this development. Part of the World Health Organization (WHO)’s strategic vision is for digital health to be supportive of equitable and […]

TATAA Biocenter has announced the promotion of Sofia Adolfsson to Head of Bioinformatics and Scientific Officer. In her new role, Sofia Adolfsson will support the company’s leadership team in its continued growth and long-term ambitions. She will spearhead the advancement of TATAA’s offerings in the realm of precision medicine, define strategic objectives and execute the […]

The investments will focus on inhaler production at Orion’s pharmaceutical plant in Espoo, production of active pharmaceutical ingredients (APIs) at Fermion’s plant in Hanko, and a pharmaceutical packaging in Salo production site. The investments will start in 2023 and will be completed by 2026. “The investments to production capacity are significant by Orion’s standards and […]

Finding out if you have cancer, through a simple test and even prior to any symptoms, would mean a more curative treatment and a much better prognosis of survival. Sweden has a few solutions with great potential well on their way. Swedish Elypta, founded in 2017, has made headlines and received several awards for their […]

Through close collaboration with Vaisala, Neutral Bioassay delivers environmental testing services with process validation services to pharmaceutical companies. The company offers process safety and effectiveness validation for virus clearance processes at both the process development and clinical trial stages. In recent years, a wide range of biological products have been used to create new drugs […]

Finland has become a hub for medical R&D, with many startups, established companies, and steps being taken to improve access to capital and provide business development expertise. While Finland has a long history of innovation, it was not until the early 2000s that healthcare and biotech began to attract significant venture capital (VC) investment. In […]

Sweden’s plethora of micro-sized and small biotech companies create a richness of innovations and a culture of knowledge sharing. To bring good science to market, they also need business intelligence and the right capital. Sweden boasts a thriving growth of micro-sized and small biotech companies that contribute to a dynamic, innovative climate and a culture […]

The company’s presence in Copenhagen positions Controlant to tap into Denmark’s strong life-science ecosystem, get closer to its customers, access a large pool of skilled professionals, and more closely collaborate with technology and industry partners, it states. Controlant is on a growth journey driven. With over 430 people from more than 40 different countries, the […]